These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9191252)

  • 21. A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma.
    Siegrist CA; Martinez-Soria E; Kern I; Mach B
    J Exp Med; 1995 Dec; 182(6):1793-9. PubMed ID: 7500024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MHC class II molecules traffic into lipid rafts during intracellular transport.
    Poloso NJ; Muntasell A; Roche PA
    J Immunol; 2004 Oct; 173(7):4539-46. PubMed ID: 15383586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM.
    Belmares MP; Busch R; Mellins ED; McConnell HM
    Biochemistry; 2003 Jan; 42(3):838-47. PubMed ID: 12534297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of mouse H2-M.
    Fremont DH; Crawford F; Marrack P; Hendrickson WA; Kappler J
    Immunity; 1998 Sep; 9(3):385-93. PubMed ID: 9768758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor.
    Hornell TM; Beresford GW; Bushey A; Boss JM; Mellins ED
    J Immunol; 2003 Sep; 171(5):2374-83. PubMed ID: 12928384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
    Peterson M; Sant AJ
    J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation.
    Fallas JL; Tobin HM; Lou O; Guo D; Sant'Angelo DB; Denzin LK
    J Immunol; 2004 Aug; 173(3):1549-60. PubMed ID: 15265882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Another twist to MHC-peptide recognition.
    Wilson IA
    Science; 1996 May; 272(5264):973-4. PubMed ID: 8638141
    [No Abstract]   [Full Text] [Related]  

  • 29. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain.
    Roche PA; Marks MS; Cresswell P
    Nature; 1991 Dec; 354(6352):392-4. PubMed ID: 1956401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules.
    Stebbins CC; Peterson ME; Suh WM; Sant AJ
    J Immunol; 1996 Dec; 157(11):4892-8. PubMed ID: 8943393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-release of CLIP in peptide loading of HLA-DR molecules.
    Kropshofer H; Vogt AB; Stern LJ; Hämmerling GJ
    Science; 1995 Nov; 270(5240):1357-9. PubMed ID: 7481823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.
    Neumann J; Eis-Hübinger AM; Koch N
    J Immunol; 2003 Sep; 171(6):3075-83. PubMed ID: 12960333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4 binding to major histocompatibility complex class II antigens induces LFA-1-dependent and -independent homotypic adhesion of B lymphocytes.
    Kansas GS; Cambier JC; Tedder TF
    Eur J Immunol; 1992 Jan; 22(1):147-52. PubMed ID: 1730248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-level intrinsic disorder explains the universality of CLIP binding to diverse MHC class II variants.
    Uversky VN; Tu YN; Nwogu O; Butler SN; Ramsamooj M; Blanck G
    Cell Mol Immunol; 2018 Jan; 15(1):76-78. PubMed ID: 28757614
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple signals regulate the intracellular trafficking of HLA-DM in B-lymphoblastoid cells.
    Copier J; Potter P; Sacks SH; Kelly AP
    Immunology; 1998 Apr; 93(4):505-10. PubMed ID: 9659222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CLIP-region mediated interaction of Invariant chain with MHC class I molecules.
    Powis SJ
    FEBS Lett; 2006 May; 580(13):3112-6. PubMed ID: 16678175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The kinetic basis of peptide exchange catalysis by HLA-DM.
    Zarutskie JA; Busch R; Zavala-Ruiz Z; Rushe M; Mellins ED; Stern LJ
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12450-5. PubMed ID: 11606721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM.
    Busch R; Reich Z; Zaller DM; Sloan V; Mellins ED
    J Biol Chem; 1998 Oct; 273(42):27557-64. PubMed ID: 9765288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
    Thayer WP; Ignatowicz L; Weber DA; Jensen PE
    J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.